Category: Research Misconduct

Real world data about dabigatran (Pradaxa)

New real world data about dabigatran released by the FDA http://t.co/weeF1m2h3I — Boehringer (@Boehringer) May 15, 2014 — The evidence does not support Boehringer statements. Xian Ying, et al. Real world effectiveness of warfarin among ischemic stroke patients with atrial fibrillation: observational analysis from Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) study 2015;…

Slippery Slope: FDA Reviewer Questions Eliquis Mortality Claim: Trial data from more than 300 patients is missing

Me señala Marc Casañas este artículo (Medpage Today) sobre apixaban (nombre comercial: Eliquis) y mortalidad. Eliquis es uno de los nuevos anticoagulantes orales (por sus siglas en Inglés: NOAC – novel oral anticoagulants) junto a dabigatran (Pradaxa), ribaroxaban (Xarelto) y edoxaban (Savaysa o Lixiana). Uno de los principales argumentos de las entidades regulatorias para aprobar el…

The University of Minnesota’s Medical Research Mess – The New York Times

By Carl Elliot. May 26, 2015 …”These days, of course, medical research is not just a scholarly affair. It is also a global, multibillion-dollar business enterprise, powered by the pharmaceutical and medical-device industries. The ethical problem today is not merely that these corporations have plenty of money to grease the wheels of university research. It’s…